BNB PLUS CORP. (BNBX)
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments. Its Therapeutic DNA Production Services division specializes in the enzymatic manufacturing of synthetic DNA, used in the creation of nucleic acid-based treatments, and also develops and markets its proprietary RNA Polymerase (RNAP) for mRNA therapeutic production. The MDx Testing Services segment concentrates on developing clinical molecular diagnostic and genetic assessments, in addition to providing comprehensive clinical laboratory testing services. Lastly, the DNA Tagging and Security Products and Services segment leverages DNA detection techniques for securing industrial supply chains and offering various security solutions.
Sector: Finance Services
Industry: Biotechnology
BNB Plus Corp.
- 0.1%
- 4.4K
- 1.00
Float 6.13M · Signal8 dilution snapshot · Sep 14, 2026
The cost to borrow BNBX shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.
- 20.4%
- 1
Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.
Latest short interest settlements (today's share basis)
| Date | Shares short |
|---|---|
| Oct 30, 2026 | 4.4K sh |
| Oct 15, 2026 | 4.4K sh |
| Sep 30, 2026 | 4.4K sh |
| Sep 15, 2026 | 4.4K sh |
| Aug 31, 2026 | 4.4K sh |
Latest fails to deliver
| Date | Shares failed |
|---|---|
| Oct 20, 2026 | 1 sh |
| Aug 6, 2026 | 1.1K sh |
| Aug 5, 2026 | 1.3K sh |
| Aug 4, 2026 | 1 sh |
| Jul 29, 2026 | 2 sh |
A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.
The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.
Latest sessions
| Date | Reported short |
|---|---|
| Nov 16, 2026 | 20.4% |
| Nov 13, 2026 | 26.0% |
| Nov 12, 2026 | 0.1% |
| Nov 9, 2026 | 59.0% |
| Nov 5, 2026 | 4.8% |
130 calendar days requested; 70 sessions published. FINRA reports this at T+1 to T+2, so the latest session is not today's.
Source: FINRA Reg SHO daily short volume, summed across the NASDAQ, NYSE and Consolidated trade reporting facilities. Covers off-exchange (over-the-counter) executions only; volume executed on an exchange is not included and is not reported short here.
Off-exchange short volume is not short interest and is not a bearish signal. When a wholesaler fills a retail buy order it sells to the customer as principal and buys back in the market, and that sale is reported as short. A high reported short share is therefore characteristic of internalised retail buying, and this figure should not be read as investors positioning against the stock.
FINRA's weekly alternative trading system (dark pool) volume for BNBX: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.
As of the Oct 30, 2026 FINRA settlement, 4,384 BNBX shares were sold short (0.07% of a 6.13M-share float, 1.00 days to cover).